![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, May 31, 2020 2:20:21 AM
Algernon clearly indicated they were in contact with the US FDA, Health Canada and Australia at the same time as they were in contact with South Korean Food and Drug Administration. South Korea submission was only 13 days before Health Canada submission. So how does that equate to them changing the narrative when the narrative was clearly stated almost 2 months ago?
Even in the last BioPub Chris Moreau mentioned that they are conducting multiple trials in different countries so they could increase the probability and likelihood of them finding a sufficient amount of severe case patients to dose. We knew at the beginning of May that the South Korean severe case COVID 19 numbers were dwindling and that them finding an ample amount of patients to dose may pose a challenge for them. Only recently has the SK numbers begun to spike again. Maybe there was a delay? There is so many things to factor in here than to just chalk it up to shady dealings. Algernon was diligent enough and had enough foresight to get multiple trials going at the same time so that they were not leaving the future of NP-120 strictly in the hands of the South Koreans.
IMO that was really smart of them to do that. But hey it's all good. I am just gotta let it all unfold and enjoy the ride.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM